ExLibris header image
SFX Logo
Title: Geranylgeranylacetone inhibits ovarian cancer progression in vitro and in vivo
Source:

Biochemical and Biophysical Research Communications [0006-291X] Hashimoto, Kae yr:2007


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Nanjundan, M. "Amplification of MDS1 EVI1 and EVI1, Located in the 3q26.2 Amplicon, Is Associated with Favorable Patient Prognosis in Ovarian Cancer." Cancer research 67.7 (2007): 3074-84. Link to SFX for this item
2. Izutsu, K. "The corepressor CtBP interacts with Evi-1 to repress transforming growth factor beta signaling." Blood 97.9 (2001): 2815-22. Link to SFX for this item
3. Kurokawa, M. "The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3." Nature 394.6688 (1998): 92-6. Link to Full Text for this item Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced